Skip to Content

VariZIG FDA Approval History

FDA Approved: Yes (First approved December 20, 2012)
Brand name: VariZIG
Generic name: varicella zoster immune globulin
Dosage form: for Injection
Company: Cangene Corporation
Treatment for: Varicella-Zoster

VariZIG is a varicella zoster immune globulin (human) intended to reduce the severity of chickenpox (varicella) infections in high risk individuals.

Development Timeline for VariZIG

DateArticle
Dec 21, 2012ApprovalFDA Approves Varizig for Reducing Chickenpox Symptoms

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.